Nutex Health, Inc. (NUTX) vs Rapport Therapeutics, Inc. Common Stock (RAPP)

A side-by-side comparison of Nutex Health, Inc. and Rapport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Nutex Health, Inc. logo
NUTX
Nutex Health, Inc.
$1.54B
$223.38HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Rapport Therapeutics, Inc. Common Stock logo
RAPP
Rapport Therapeutics, Inc. Common Stock
$1.49B
$31.07HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — NUTX vs RAPP

growth of $100 · dividends reinvested · last 2y
NUTX +3437.7% (+494.8%/yr)RAPP +54.8% (+24.4%/yr)NUTX compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020252026$3,538$155
NUTX RAPP

NUTX vs RAPP: by the numbers

  • •NUTX is the larger company ($1.54B vs $1.49B market cap).
  • •NUTX is profitable (21.25% net margin) while RAPP runs a net loss (-685.80%).

Metrics side by side

Valuation

MetricNUTXRAPP
P/E ratio8.84N/A
Forward P/E8.04N/A
P/S ratio1.8274.29
P/B ratio3.903.51
EV / EBITDA4.36N/A
FCF yield17.84%N/A

Profitability

MetricNUTXRAPP
Gross margin51.26%0.00%
Operating margin31.49%0.00%
Net margin21.25%-685.80%
ROE45.63%-32.43%
ROIC33.76%-35.66%

Growth (annualized)

MetricNUTXRAPP
Revenue CAGR (5Y)37.66%N/A
EPS CAGR (5Y)-14.73%N/A
Total return CAGR (5Y)-18.99%N/A

Frequently asked

Is NUTX or RAPP more profitable?
NUTX runs the higher net margin — NUTX at 21.25% versus RAPP at -685.80%.

Go deeper

Full NUTX analysisFull RAPP analysisInteractive comparison tool

Dig into the metrics

Nutex Health P/E ratioNutex Health ROERapport Therapeutics, Inc. Common Stock ROENutex Health operating marginRapport Therapeutics, Inc. Common Stock operating marginNutex Health revenue growthRapport Therapeutics, Inc. Common Stock revenue growthNutex Health free cash flowRapport Therapeutics, Inc. Common Stock free cash flow

Nutex Health & Rapport Therapeutics, Inc. Common Stock appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksHighest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.